Upstate Active Clinical Trials

Study Title:

Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients.

What is the purpose of the study?

Randomized treatment study to look at effects of combination chemotherapy with or without rituximab in treating younger patients with stage III or stage IV non-Hodgkin lymphoma or B-cell acute leukemia.

Upstate Institutional Review Board (IRB) Number:

361624

Study/Protocol ID:

ANHL1131

Study Phase:

II/III

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT01595048

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again